Stock 24H HANSA BIOPHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Hansa Biopharma AB Börse Stuttgart

Equities

24H

SE0002148817

Delayed Börse Stuttgart
Other stock markets
 07:07:27 24/06/2024 BST 		5-day change 1st Jan Change
3.676 EUR -0.22% Intraday chart for Hansa Biopharma AB -7.36% +56.83%
05-31 Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial MT
05-31 Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial CI

Chart calendar Hansa Biopharma AB

c1f60.xGoCEZgqk-uOKOxQowWGwRqleH5qwBDbjhE91fZbiJg.kwxDW_5SorPPHqgbxFTNq3-VQToggX2L6WVLgaJtwcz0CFJL0UP5rcBuiw~72dc8ceaed0b9738a0878709ba2bdb7f

Upcoming events on Hansa Biopharma AB

26/06/2024 Annual General Meeting
17/07/2024 Q2 2024 Earnings Release
08/09/2024 H.C. Wainwright Global Investment Conference
18/09/2024 Pareto Securities Healthcare Conference
24/10/2024 07:00 Q3 2024 Earnings Release
29/01/2025 Q4 2024 Earnings Release (Projected)
16/04/2025 Q1 2025 Earnings Release (Projected)
16/07/2025 Q2 2025 Earnings Release (Projected)
15/10/2025 Q3 2025 Earnings Release (Projected)

Past events on Hansa Biopharma AB

10/06/2024 ABG Digitital Autoimmunity, Transplantation, and Inflammation Conference
05/06/2024 14:40 American Transplant Congress
04/06/2024 15:15 American Transplant Congress
04/06/2024 14:15 American Transplant Congress
03/06/2024 18:40 American Transplant Congress
02/06/2024 14:15 American Transplant Congress
26/05/2024 Roadshow
13/05/2024 Capital One Biotech Disruptors Conference
21/04/2024 Roadshow
18/04/2024 13:00 Q1 2024 Earnings Call
18/04/2024 06:00 Q1 2024 Earnings Release
15/04/2024 Van Lanschot Kempen Life Sciences Conference
07/04/2024 Needham Healthcare Conference
03/03/2024 TD Cowen Health Care Conference
27/02/2024 Ökonomisk Ugebrev Life Science Conference
13/02/2024 Redeye Regenerative Medicine/Cell Therapy Event
05/02/2024 Frankfurt MidCap Conference
02/02/2024 13:00 Q4 2023 Earnings Call
02/02/2024 06:31 Q4 2023 Earnings Release
07/01/2024 JPMorgan Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million SEK		Released
Forecast
Spread 		3,40
3,04
11.84%		6,10
9,00
-32.24%		33,9
32,4
4.53%		155
146
5.55%		134
134
0.31%
252

EBITDA
Million SEK		Released
Forecast
Spread 		-352
-360
2.24%		-420
-394
-6.6%		-538
-501
-7.44%		-577
-565
-2.1%		-769
-754
-1.96%
-529

EBIT
Million SEK		Released
Forecast
Spread 		-360
-357
-0.84%		-423
-406
-4.24%		-547
-538
-1.65%		-587
-586
-0.11%		-788
-781
-1.02%
-589

Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread 		-360
-356
-1.15%		-421
-396
-6.17%		-548
-506
-8.37%		-608
-600
-1.32%		-831
-861
3.52%
-679

Net income
Million SEK		Released
Forecast
Spread 		-360
-356
-1.25%		-421
-396
-6.17%		-548
-506
-8.41%		-610
-601
-1.46%		-832
-864
3.71%
-679

EPS
SEK		Released
Forecast
Spread 		-9,00
-8,82
-2.04%		-9,98
-9,40
-6.13%		-12,3
-11,3
-9.41%		-13,6
-12,8
-5.91%		-15,8
-16,3
2.67%
-10,9

Announcement Date06/02/2004/02/2103/02/2202/02/2302/02/24-

Quarterly results

Fiscal PeriodDecember 2021 S1 2021 S2 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million SEK		Released
Forecast
Spread 		13,5
24,0
-43.75%		20,4
25,0
-18.4%		30,3
5,28
473.81%		26,4
15,0
75.72%		67,1
23,7
183.18%		30,8
31,0
-0.83%		24,2
30,7
-21.12%		36,7
35,6
3.01%		22,8
22,8
0%		50,4
50,0
0.82%		56,0
54,0
3.7%
50,7


70,4


61,8


67,8


71,8

EBITDA
Million SEK		Released
Forecast
Spread





-135
0,00
- 		-167
0,00
- 		-139
0,00
-



-116


-164


-136


-141





-153


-108


-127







EBIT
Million SEK		Released
Forecast
Spread 		-236
-214
-10.28%		-311


-135
-82,7
-63.21%		-168
0,00
- 		-139
-171
18.56%		-145
-177
18.33%		-182
-137
-32.86%		-228
-169
-35.03%		-202
-193
-4.78%		-176
-169
-3.92%		-159
-170
6.35%
-161


-142


-150







Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread 		-237
-214
-10.53%		-312
-265
-17.58%		-138
-165
16.37%


-153
-173
11.19%		-147
-184
20.49%		-205
-160
-28.17%		-251
-188
-33.76%		-250
-217
-15.21%		-124
-196
36.59%		-219
-174
-25.82%
-176


-170


-171







Net income
Million SEK		Released
Forecast
Spread 		-237
-214
-10.52%		-312
-265
-17.66%		-138
-82,7
-67.33%		-170
0,00
- 		-154
-173
10.9%		-147
-183
19.7%


-251
-188
-33.69%		-251
-217
-15.31%		-124
-196
36.49%		-219
-174
-25.77%
-176


-170


-171







EPS
SEK		Released
Forecast
Spread 		-5,32
-4,80
-10.83%		-7,01
-6,00
-16.83%		-3,11
-1,81
-72.3%		-3,82
-1,88
-103.73%		-3,45
-3,80
9.21%		-3,19
-4,14
22.95%		-3,92
-3,53
-11.05%		-4,79
-3,55
-35.12%		-4,78
-3,98
-20.25%		-2,36
-3,72
36.5%		-4,15
-3,19
-30.09%
-2,72


-2,50


-2,45


-2,46


-2,48

Announcement Date15/07/2103/02/2221/04/2219/07/2220/10/2202/02/2320/04/2320/07/2326/10/2302/02/2418/04/24-----

Upcoming sector events for Hansa Biopharma AB

15/07/2024 06:45 ADDLIFE AB: Q2 2024 Earnings Release
21/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
23/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
23/07/2024 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
24/07/2024 LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 06:00 BACHEM HOLDING AG: Q2 2024 Earnings Release
25/07/2024 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 06:00 BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for Hansa Biopharma AB

07/06/2024 07:57 POLARIS GROUP: May 2024 Sales and Revenue Release
29/05/2024 21:01 IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 12:00 CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 06:00 EVOTEC SE: Q1 2024 Earnings Release
21/05/2024 22:14 ALVOTECH: Q1 2024 Earnings Release
21/05/2024 12:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
17/05/2024 07:00 BIOARCTIC AB: Q1 2024 Earnings Release
15/05/2024 21:05 CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. HNSA Stock
  4. 24H Stock
  5. Calendar Hansa Biopharma AB